KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Current Deferred Revenue (2017 - 2020)

Novartis Ag (NVS) has disclosed Current Deferred Revenue for 4 consecutive years, with $56.0 million as the latest value for Q4 2020.

  • Quarterly Current Deferred Revenue fell 50.88% to $56.0 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $56.0 million through Dec 2020, down 50.88% year-over-year, with the annual reading at $56.0 million for FY2020, 50.88% down from the prior year.
  • Current Deferred Revenue hit $56.0 million in Q4 2020 for Novartis Ag, down from $114.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $305.0 million in Q4 2017 to a low of $56.0 million in Q4 2020.
  • Historically, Current Deferred Revenue has averaged $177.8 million across 4 years, with a median of $175.0 million in 2018.
  • Biggest five-year swings in Current Deferred Revenue: decreased 22.62% in 2018 and later plummeted 51.69% in 2019.
  • Year by year, Current Deferred Revenue stood at $305.0 million in 2017, then decreased by 22.62% to $236.0 million in 2018, then tumbled by 51.69% to $114.0 million in 2019, then tumbled by 50.88% to $56.0 million in 2020.
  • Business Quant data shows Current Deferred Revenue for NVS at $56.0 million in Q4 2020, $114.0 million in Q4 2019, and $236.0 million in Q4 2018.